摘要
目的观察肺结核强化抗痨治疗临床转归与血清游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、反三碘甲状腺原氨酸(γT3)水平的关系。方法对71例肺结核患者强化抗痨治疗前后血清FT3、FT4、γT3进行动态观察。结果强化治疗后好转组35例的血清FT3、FT4分别由(4.87±3.06)pmol/L、(15.55±5.77)pmol/L升至(5.79±3.31)pmol/L、(18.27±5.36)pmol/L,γT3由(0.42±0.18)nmol/L降至(0.29±0.12)nmol/L;恶化或无变化组36例的血清FT3、FT4分别由(3.56±2.38)pmol/L、(12.74±5.19)pmol/L降至(3.26±1.44)pmol/L、(11.63±4.96)pmol/L,γT3由(0.46±0.28)nmol/L升至(0.73±0.29)nmol/L。结论动态观察血清FT3、FT4、γT3的变化对评价强化抗痨疗效有一定临床意义。
Objective To study the relation between the clinicle turns to return of anti-tuberculosis treatment and the change of FT3 , FT4 , γT3. Methods The serum FT3 , FT4 , γT3 of 71 patients were observed before and after treatment. Results The serum FT3, FT4 ,γT3 of 35 patients which were amendment set differences from （4. 87 ± 3.06）pmol/L, （ 15.55 ± 5.77）pmol/L rise to （5.79 ± 3.31 ）pmol/L, （18.27 ± 5.36）pmol/L, γT3 from （0.42 ± 0.18） nmol/L decline to （0.29 ± 0.12）pmol/L. The serum FT3 ,FT4 ,γT3 of 36 patients which were depravation set or had no chage set differences from （3.56 ± 2.38）pmol/L, （12.74 ± 5.19）pmol/L decline to （3.26 ± 1.44 ） pmol/L, （11.63 ± 4.96 ） pmol/L, γT3 from （ 0.46 ± 0.28 ） nmol/L rise to （0.73 ± 0.29 ） nmol/L. Conclusion There is clinical significance to evaluate the curative effect of the anti-tuberculosis with the change of serum FT3 , FT4, γT3.
出处
《中国基层医药》
CAS
2005年第9期1223-1224,共2页
Chinese Journal of Primary Medicine and Pharmacy
